September 18, 2023 02:36 PM EDTUpdated September 19, 05:33 PM

AstraZeneca rolls up cardiovascular, renal and metabolic interconnections in film and digital effort

Beth Snyder Bulik

Senior Editor

AstraZeneca is putting its cardiovascular, renal and metabolic (CVRM) portfolio in the spotlight with a short film and digital campaign. The two-minute

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AstraZeneca rolls up cardiovascular, renal and metabolic interconnections in film and digital effort

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

As­traZeneca rolls up car­dio­vas­cu­lar, re­nal and meta­bol­ic in­ter­con­nec­tions in film and dig­i­tal ef­fort

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AstraZeneca rolls up cardiovascular, renal and metabolic interconnections in film and digital effort